COMPOUNDS THAT INTERACT WITH THE RAS SUPERFAMILY FOR THE TREATMENT OF CANCERS… Application EP-4331679-A2 European Patent Office 06 Mar 2024
T-CELL RECEPTORS SPECIFIC FOR BOTH RAC1- AND RAC2-DERIVED MUTATED EPITOPES Application EP-4079753-A1 European Patent Office 26 Oct 2022
T-CELL RECEPTORS SPECIFIC FOR BOTH RAC1- AND RAC2-DERIVED MUTATED EPITOPES Application WO-2022219155-A1 World Intellectual Property Organisation (WIPO) 20 Oct 2022
SUBSTITUTED THIENOPYRIMIDINES THAT INTERACT WITH THE RAS SUPERFAMILY FOR THE TREATMENT OF… Application WO-2021257828-A1 World Intellectual Property Organisation (WIPO) 23 Dec 2021